Vera Therapeutics Inc. has announced new compensation terms for eight new employees, involving inducement awards under the company's 2024 Inducement Plan. The awards include non-qualified stock options to purchase 85,000 shares of Class A common stock and restricted stock units (RSUs) for 45,250 shares. The stock options are set at an exercise price of $21.90 per share and will vest over four years, with 25% vesting after the first year and the remainder monthly over the next 36 months. The RSUs will also vest over four years, with 25% of shares vesting annually.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9524150-en) on September 05, 2025, and is solely responsible for the information contained therein.